Quidel | QDEL - Ebitda

Stock Price
10.32
Daily Change
-1.07 -9.39%
Monthly
-18.64%
Yearly
-69.16%
Q2 Forecast
10.11

Quidel reported $108.7M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
Agilent USD 540M 74M Sep/2025
Avanos Medical USD 13M 3M Dec/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Bruker USD 110M 101.6M Mar/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Danaher USD 1.92B 204M Mar/2026
Haemonetics USD 94.78M 20.75M Dec/2025
Illumina USD 469M 137M Dec/2025
IQVIA Holdings USD 932M 114M Mar/2026
Merit Medical Systems USD 97.23M 17.69M Dec/2025
Mettler Toledo International USD 278.99M 100.24M Mar/2026
Myriad Genetics USD 14.3M 4M Dec/2025
Neogen USD 48.2M 546K Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Pacific Biosciences Of California USD -35.4M 5.78M Sep/2025
Quidel USD 108.7M 44.6M Mar/2026
Revvity USD 272.91M 24M Mar/2026
STAAR Surgical USD -159K 34.78M Dec/2025
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Waters USD 380.97M 85.83M Dec/2025